IDEXX LABORATORIES INC /DE Quarterly Income Tax Expense (Benefit) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Idexx Laboratories Inc /De quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2010 to Q3 2024.
  • Idexx Laboratories Inc /De Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $66.1M, a 18.7% increase year-over-year.
  • Idexx Laboratories Inc /De Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $227M, a 7.02% increase year-over-year.
  • Idexx Laboratories Inc /De annual Income Tax Expense (Benefit) for 2023 was $216M, a 19.5% increase from 2022.
  • Idexx Laboratories Inc /De annual Income Tax Expense (Benefit) for 2022 was $181M, a 14.6% increase from 2021.
  • Idexx Laboratories Inc /De annual Income Tax Expense (Benefit) for 2021 was $158M, a 97.6% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $227M $66.1M +$10.4M +18.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $216M $55.8M -$5.94M -9.62% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $222M $59.9M +$6.27M +11.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $216M $45.1M +$4.14M +10.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $212M $55.7M +$2.42M +4.54% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $210M $61.7M +$22.6M +57.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $187M $53.6M +$6.11M +12.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 $181M $41M +$11.9M +40.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $169M $53.2M +$9.47M +21.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $160M $39.1M -$10M -20.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $170M $47.5M +$11.7M +32.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $158M $29.1M +$26.6M +1075% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $131M $43.8M +$26.1M +148% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $105M $49.1M +$14.3M +41.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $90.7M $35.8M +$10.9M +43.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $79.9M $2.48M -$15.5M -86.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-16
Q3 2020 $95.3M $17.6M -$6.33M -26.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $102M $34.8M +$4.41M +14.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $97.3M $24.9M +$2.83M +12.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $94.4M $18M -$3.41M -15.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-16
Q3 2019 $97.8M $24M +$8.14M +51.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $89.7M $30.4M +$1.79M +6.26% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $87.9M $22.1M +$7.21M +48.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q4 2018 $80.7M $21.4M -$30M -58.4% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-12
Q3 2018 $111M $15.8M -$5.71M -26.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $116M $28.6M -$549K -1.88% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $117M $14.9M -$806K -5.14% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 $118M $51.4M +$26.6M +108% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-14
Q3 2017 $91.1M $21.5M -$3.54M -14.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $94.7M $29.2M -$502K -1.69% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 $95.2M $15.7M -$4.61M -22.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $99.8M $24.8M +$9.36M +60.8% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-15
Q3 2016 $90.4M $25.1M +$4.47M +21.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 $86M $29.7M +$5.02M +20.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 $80.9M $20.3M -$62K -0.31% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-28
Q4 2015 $81M $15.4M +$11.5M +294% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-16
Q3 2015 $69.5M $20.6M +$4.56M +28.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-01
Q2 2015 $65M $24.7M +$1.17M +4.97% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-02
Q1 2015 $63.8M $20.3M -$804K -3.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-04-29
Q4 2014 $64.6M $3.91M -$12.8M -76.6% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-17
Q3 2014 $77.4M $16M -$2.74M -14.6% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-28
Q2 2014 $80.2M $23.5M -$531K -2.21% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-30
Q1 2014 $80.7M $21.2M +$5.22M +32.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-28
Q4 2013 $75.5M $16.7M -$3M -15.2% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-17
Q3 2013 $78.5M $18.8M -$853K -4.34% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-24
Q2 2013 $79.3M $24M -$22K -0.09% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-25
Q1 2013 $79.3M $15.9M -$2.99M -15.8% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-25
Q4 2012 $82.3M $19.7M +$3.03M +18.1% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-17
Q3 2012 $79.3M $19.6M +$2.52M +14.7% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-22
Q2 2012 $76.8M $24.1M +$1.77M +7.94% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-23
Q1 2012 $75M $18.9M +$2.35M +14.2% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-23
Q4 2011 $72.7M $16.7M +$2.61M +18.5% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-18
Q3 2011 $70.1M $17.1M +$2.57M +17.7% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-19
Q2 2011 $67.5M $22.3M +$5.19M +30.4% Apr 1, 2011 Jun 30, 2011 10-Q 2012-07-20
Q1 2011 $62.3M $16.6M +$1.48M +9.8% Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-20
Q4 2010 $60.8M $14.1M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-19
Q3 2010 $14.5M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-21
Q2 2010 $17.1M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-22
Q1 2010 $15.1M Jan 1, 2010 Mar 31, 2010 10-Q 2011-04-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.